ArticleFrontiers in oncology2023

First-line programmed death-1 inhibitor treatment for locoregionally advanced or metastatic cutaneous squamous cell carcinoma - A real-world experience from Israel.

Itamar Averbuch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.